Extracellular vesicles (EVs) present numerous biomedical ways of studying disease and
pathology. They function as protective packaging for the delivery of controlled …

Fibrosis is likely to occur in many tissues and organs to induce cicatrisation and dysfunction.
The therapeutic regimens for delaying and even reversing fibrosis are quite limited at …

Mesenchymal stem cells (MSCs) are mesenchymal precursors of various origins, with well‐
known immunomodulatory effects. Natural killer (NK) cells, the major cells of the innate …

In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan city, Hubei province,
China. Rapidly escalated into a worldwide pandemic, it has caused an unprecedented and …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial fibrotic disease that leads to
disability and death within 5 years of diagnosis. Pulmonary fibrosis is a disease with a …

Microvascular pericytes have been demonstrated as an origin for myofibroblasts that
produce excessive extracellular matrix (ECM) proteins such as α-smooth muscle actin (α …

Mesenchymal stem cells (MSCs) possess a role in tissue regeneration and homeostasis
because of inherent immunomodulatory capacity and the production of factors that …

Idiopathic pulmonary fibrosis (IPF) is one of the most aggressive forms of idiopathic
interstitial pneumonias, characterized by chronic and progressive fibrosis subverting the …

Treating premature infants with high oxygen is a routine intervention in the context of
neonatal intensive care. Unfortunately, the increase in survival rates is associated with …

Pulmonary fibrosis is closely associated with the recruitment of fibroblasts from capillary
vessels with damaged endothelial cells, the epithelial mesenchymal transition (EMT) of type …